Shares of Altamira Therapeutics (CYTO) have been struggling lately and have lost 16.6% over the past four weeks. However, a hammer chart pattern was formed in its last trading session, which could ...
Nasdaq Analyst Research provides analyst research for ratings consensus and a summary of stock price targets. Analysts evaluate the stock’s expected performance in a given time period based on their ...
Altamira Therapeutics (NASDAQ:CYTO) stock is rocketing higher on Friday following the release of positive results from a nasal spray test. woman in a white shirt wearing a face mask while at an ...
FORT COLLINS, Colo., Feb. 16, 2021 /PRNewswire/ -- Cytocom, Inc., a leading biopharmaceutical company creating first second-generation immune therapies, today provided an update regarding its CYTO-200 ...
Sphere Fluidics, a leading provider of innovative droplet-based microfluidics solutions for single-cell analysis and isolation, today shared details of Cyto-Mine® Chroma, the second generation of its ...
Sphere Fluidics, a leading provider of innovative microfluidics-based solutions for single-cell analysis and isolation, today announced the launch of Cyto-Cellect® Fc Fusion, a novel assay designed to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results